Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $673.64M.
ENTERPRISE VALUE (EV)
$673.64M
Prime Medicine, Inc.
Market Cap
$628.39M
Enterprise Value (EV)
$673.64M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Prime Medicine, Inc. (PRME) | $628.39M | $673.64M |
| Climb Bio, Inc. (CLYM)vs › | $631.04M | $588.25M |
| SOPHiA GENETICS S.A. (SOPH)vs › | $631.73M | $585.89M |
| Aura Biosciences, Inc. (AURA)vs › | $632.00M | $580.75M |
| OmniAb, Inc. (OABI)vs › | $648.75M | $643.33M |
| Starling Oncology, Inc. (STLN)vs › | $657.89M | $721.27M |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $598.37M | $916.11M |
| AngioDynamics, Inc. (ANGO)vs › | $598.08M | $544.22M |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $665.51M | $634.36M |
| OrthoPediatrics Corp. (KIDS)vs › | $590.50M | $665.09M |
Market Cap
$628.39M
Total Debt
$108.29M
Cash
$63.03M
Enterprise Value
$673.64M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
